Biomarkers of oxidative stress in fetal and neonatal diseases

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 12, 2012, Pages 2575-2578

  Perrone, Serafina ^a   Tataranno, Maria Luisa ^a   Stazzoni, Gemma ^a   Buonocore, Giuseppe ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Free radicals; Isoprostanes; Lipid peroxidation; Newborn infants; Nonprotein bound iron; Oxidative stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER; CARBONYLATED PROTEIN DERIVATIVE; FREE RADICAL; HYDROPEROXIDE; ISOFURAN DERIVATIVE; ISOPROSTANE DERIVATIVE; LIPID; NEUROFURAN DERIVATIVE; NEUROPROSTANE; NON PROTEIN BOUND IRON; NUCLEIC ACID; POLYSACCHARIDE; PROTEIN; UNCLASSIFIED DRUG;

DISEASE SEVERITY; DNA DAMAGE; FETUS; FETUS DISEASE; HUMAN; LIPID PEROXIDATION; NEWBORN; NEWBORN DISEASE; OXIDATIVE STRESS; PATHOGENESIS; PERINATAL PERIOD; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

ANTIOXIDANTS; BIOLOGICAL MARKERS; FEMALE; FETAL DISEASES; FREE RADICALS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; OXIDATIVE STRESS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84870344755     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.718004     Document Type: Review

References (33)

1. Perrone S, Tataranno ML, Negro S, Longini M, Marzocchi B, Proietti F, Iacoponi F, et al. Early identification of the risk for free radical-related diseases in preterm newborns. Early Hum Dev 2010;86:241-244.
2. Halliwell B. The wanderings of a free radical. Free Radic Biol Med 2009;46:531-542.
3. Longini M, Perrone S, Kenanidis A, Vezzosi P, Marzocchi B, Petraglia F, Centini G, Buonocore G. Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy. Free Radic Biol Med 2005;38:1537-1541. (Pubitemid 40703925)
4. Longini M, Perrone S, Vezzosi P, Marzocchi B, Kenanidis A, Centini G, Rosignoli L, Buonocore G. Association between oxidative stress in pregnancy and preterm premature rupture of membranes. Clin Biochem 2007;40:793-797. (Pubitemid 46961962)
5. Frosali S, Di Simplicio P, Perrone S, Di Giuseppe D, Longini M, Tanganelli D, Buonocore G. Glutathione recycling and antioxidant enzyme activities in erythrocytes of term and preterm newborns at birth. Biol Neonate 2004;85:188-194. (Pubitemid 38437701)
6. Ciccoli L, Rossi V, Leoncini S, Signorini C, Paffetti P, Bracci R, Buonocore G, Comporti M. Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns. Free Radic Res 2003;37:51-58. (Pubitemid 36124330)
7. Buonocore G, Perrone S, Tataranno ML. Oxygen toxicity: chemistry and biology of reactive oxygen species. Semin Fetal Neonatal Med 2010;15:186-190.
8. Perrone S, Vezzosi P, Longini M, Marzocchi B, Paffetti P, Bellieni CV, Martinelli S, Buonocore G. Biomarkers of oxidative stress in babies at high risk for retinopathy of prematurity. Front Biosci (Elite Ed) 2009;1:547-552.
9. Perrone S, Tataranno ML, Negro S, Cornacchione S, Longini M, Proietti F, Soubasi V, et al. May oxidative stress biomarkers in cord blood predict the occurrence of necrotizing enterocolitis in preterm infants? J Matern Fetal Neonatal Med 2012;25 Suppl 1:128-131.
10. Bonassi S, Au WW. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat Res 2002;511:73-86. (Pubitemid 34241514)
11. Ogino K, Wang DH. Biomarkers of oxidative/nitrosative stress: an approach to disease prevention. Acta Med Okayama 2007;61:181-189. (Pubitemid 47502130)
12. Casetta B, Longini M, Proietti F, Perrone S, Buonocore G. Development of a fast and simple LC-MS/MS method for measuring the F2-isoprostanes in newborns. J Matern Fetal Neonatal Med 2012;25 Suppl 1:114-118.
13. Arneson KO, Roberts LJ 2nd. Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans. Meth Enzymol 2007;433:127-143.
14. Balduini W, Carloni S, Perrone S, Bertrando S, Tataranno ML, Negro S, Proietti F, et al. The use of melatonin in hypoxic-ischemic brain damage: an experimental study. J Matern Fetal Neonatal Med 2012;25 Suppl 1:119-124.
15. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol 2005;202:199-211. (Pubitemid 40040559)
16. Paffetti P, Perrone S, Longini M, Ferrari A, Tanganelli D, Marzocchi B, Buonocore G. Non-protein-bound iron detection in small samples of biological fluids and tissues. Biol Trace Elem Res 2006;112:221-232. (Pubitemid 44624062)
17. Buonocore G, Zani S, Sargentini I, Gioia D, Signorini C, Bracci R. Hypoxia-induced free iron release in the red cells of newborn infants. Acta Paediatr 1998;87:77-81. (Pubitemid 28086610)
18. Nyska A, Kohen R. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002;30:620-630.
19. Buonocore G, Zani S, Perrone S, Caciotti B, Bracci R. Intraerythrocyte nonprotein-bound iron and plasma malondialdehyde in the hypoxic newborn. Free Radic Biol Med 1998;25:766-770. (Pubitemid 28512528)
20. Signorini C, Perrone S, Sgherri C, Ciccoli L, Buonocore G, Leoncini S, Rossi V, et al. Plasma esterified F2-isoprostanes and oxidative stress in newborns: role of nonprotein-bound iron. Pediatr Res 2008;63:287-291. (Pubitemid 351301458)
21. Ozawa H, Nishida A, Mito T, Takashima S. Immunohistochemical study of ferritin-positive cells in the cerebellar cortex with subarachnoidal hemorrhage in neonates. Brain Res 1994;651:345-348. (Pubitemid 24222887)
22. Buonocore G, Perrone S, Longini M, Paffetti P, Vezzosi P, Gatti MG, Bracci R. Non protein bound iron as early predictive marker of neonatal brain damage. Brain 2003;126:1224-1230. (Pubitemid 36522963)
23. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-1313. (Pubitemid 26166404)
24. Alderman CJ, Shah S, Foreman JC, Chain BM, Katz DR. The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med 2002;32:377-385. (Pubitemid 34178347)
25. Buonocore G, Perrone S, Longini M, Terzuoli L, Bracci R. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res 2000;47:221-224. (Pubitemid 30075632)
26. Buonocore G, Perrone S, Longini M, Vezzosi P, Marzocchi B, Paffetti P, Bracci R. Oxidative stress in preterm neonates at birth and on the seventh day of life. Pediatr Res 2002;52:46-49. (Pubitemid 34665949)
27. Marzocchi B, Perrone S, Paffetti P, Magi B, Bini L, Tani C, Longini M, Buonocore G. Nonprotein-bound iron and plasma protein oxidative stress at birth. Pediatr Res 2005;58:1295-1299.
28. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003;329:23-38. (Pubitemid 36187411)
29. Dennery PA. Role of redox in fetal development and neonatal diseases. Antioxid Redox Signal 2004;6:147-153. (Pubitemid 38063986)
30. Perrone S, Longini M, Bellieni CV, Centini G, Kenanidis A, De Marco L, Petraglia F, Buonocore G. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome. Clin Biochem 2007;40:177-180. (Pubitemid 46108711)
31. Mehar Sulthana S, Nandha Kumar S, Sridhar MG, Vishnu Bhat B, Ramachandra Rao K. Levels of non enzymatic antioxidants in Down syndrome. Indian J Pediatr 2012; DOI: 10.1007/s12098-012-0795-8.
32. Pallardó FV, Lloret A, Lebel M, d'Ischia M, Cogger VC, Le Couteur DG, Gadaleta MN, et al. Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome. Biogerontology 2010;11:401-419.
33. Comporti M, Signorini C, Leoncini S, Buonocore G, Rossi V, Ciccoli L. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med 2004;37:724-732. (Pubitemid 38993518)